Trial intelligence / Profile preview

Warfarin vs Aspirin for Stroke Prevention in AF with CKD

NCT01668901Phase 4Withdrawn

Sponsor
Seoul National University Hospital
Start
Sep 2012
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of warfarin in Atrial fibrillation (AFib), sponsored by Seoul National University Hospital. Planned start Sep 2012; status: withdrawn.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01668901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01668901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call